Matches in DBpedia 2015-04 for { <http://dbpedia.org/resource/Tocilizumab> ?p ?o }
Showing triples 1 to 71 of
71
with 100 triples per page.
- Tocilizumab abstract "Tocilizumab (INN, or atlizumab, developed by Hoffmann–La Roche and Chugai and sold under the trade names Actemra and RoActemra) is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of RA in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer.".
- Tocilizumab atcPrefix "L04".
- Tocilizumab atcSuffix "AC07".
- Tocilizumab casNumber "375823-41-9".
- Tocilizumab fdaUniiCode "I031V2H011".
- Tocilizumab wikiPageID "9134392".
- Tocilizumab wikiPageRevisionID "629099909".
- Tocilizumab atcPrefix "L04".
- Tocilizumab atcSuffix "AC07".
- Tocilizumab c "6428".
- Tocilizumab casNumber "375823".
- Tocilizumab chembl "1237022".
- Tocilizumab chemspiderid "NA".
- Tocilizumab eliminationHalfLife "1209600.0".
- Tocilizumab h "9976".
- Tocilizumab hasPhotoCollection Tocilizumab.
- Tocilizumab kegg "D02596".
- Tocilizumab legalStatus "Rx-only".
- Tocilizumab licenceEu "RoActemra".
- Tocilizumab licenceUs "Tocilizumab".
- Tocilizumab mabType "mab".
- Tocilizumab medlineplus "a611004".
- Tocilizumab molecularWeight "145".
- Tocilizumab n "1720".
- Tocilizumab o "2018".
- Tocilizumab pregnancyUs "C".
- Tocilizumab routesOfAdministration "Intravenous infusion, subcutaneous injection".
- Tocilizumab s "42".
- Tocilizumab source "zu/o".
- Tocilizumab target Interleukin-6_receptor.
- Tocilizumab tradename "Actemra, RoActemra".
- Tocilizumab type "mab".
- Tocilizumab unii "I031V2H011".
- Tocilizumab verifiedfields "changed".
- Tocilizumab verifiedrevid "477864483".
- Tocilizumab subject Category:Immunosuppressants.
- Tocilizumab type Agent114778436.
- Tocilizumab type CausalAgent100007347.
- Tocilizumab type Drug103247620.
- Tocilizumab type Immunosuppressant103562958.
- Tocilizumab type Immunosuppressants.
- Tocilizumab type Matter100020827.
- Tocilizumab type Medicine103740161.
- Tocilizumab type PhysicalEntity100001930.
- Tocilizumab type Substance100020090.
- Tocilizumab type Drug.
- Tocilizumab type DrugProduct.
- Tocilizumab type Thing.
- Tocilizumab type Q8386.
- Tocilizumab comment "Tocilizumab (INN, or atlizumab, developed by Hoffmann–La Roche and Chugai and sold under the trade names Actemra and RoActemra) is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of RA in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R).".
- Tocilizumab label "Tocilizumab".
- Tocilizumab label "Tocilizumab".
- Tocilizumab label "Tocilizumab".
- Tocilizumab label "Tocilizumab".
- Tocilizumab label "Tocilizumab".
- Tocilizumab label "Tocilizumab".
- Tocilizumab label "Tocilizumabe".
- Tocilizumab label "トシリズマブ".
- Tocilizumab sameAs Tocilizumab.
- Tocilizumab sameAs Tocilizumab.
- Tocilizumab sameAs Tocilizumab.
- Tocilizumab sameAs Tocilizumab.
- Tocilizumab sameAs トシリズマブ.
- Tocilizumab sameAs Tocilizumab.
- Tocilizumab sameAs Tocilizumabe.
- Tocilizumab sameAs m.027yz2q.
- Tocilizumab sameAs Q425154.
- Tocilizumab sameAs Q425154.
- Tocilizumab sameAs Tocilizumab.
- Tocilizumab wasDerivedFrom Tocilizumab?oldid=629099909.
- Tocilizumab isPrimaryTopicOf Tocilizumab.